InteRNA Technologies and Cenix BioScience this week announced that they plan to use InteRNA’s microRNA library to co-develop functional screens for human cell lines.
 
An InteRNA official told CBA News this week that Cenix will apply InteRNA’s lentiviral-based miRNA-overexpression library to high-throughput screening assays in combination with high-content, multi-parametric phenotypic analyses to identify the biological role of individual miRNAs and novel therapeutic targets in oncology.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.